International business travel to under-developed and developing countries has increased considerably over the past two decades. Most of these destinations are endemic to a variety of infectious diseases, many of which are associated with considerable morbidity, mortality, or both and the nonimmune, unprepared corporate traveler is at risk. Comprehensive pretravel consultation is essential to prevent travel-related illness. This review addresses some of the infectious diseases that can be acquired during international travel, including regions of endemicity, assessment of risk, and available means of prevention. In addition, we discuss data concerning current practices and attitudes of travelers, along with some of the issues surrounding the counseling of corporate travelers.
From DST Output (Dr Hudson), El Dorado Hills, CA; Department of Family and Community Medicine (Dr Hudson), University of California Davis Medical Center, Sacramento, CA; and Delphi E&C Division (Dr Fortuna)
The content of this supplement was discussed and guided during a roundtable meeting attended by Dr. Bradley A. Connor, William B. Bunn, Douglas Patron, T. Warner Hudson, Joseph A. Fortuna and Pamela Hymel. The authors did not receive financial compensation for writing these manuscripts.
Address correspondence to: T. Warner Hudson, MD, FACOEM, FAAFP, DST Output, 5220 Robert J Mathews Pkwy, El Dorado Hills, CA 95762; E-mail: WHudson@dstoutput.com.